Samsung’s V6 ultrasound system for women’s health and urology gets FDA clearance.
V6 features AI-powered imaging, including miniER7 transducer, ViewAssist™, BiometryAssist™, and UterineAssist™.
V6 integrates with Cycle Clarity’s AI software for fertility treatment.
Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound business, has unveiled its latest ultrasound system, the V6, designed for Women’s Health and Urology. The system recently received 510(k) clearance from the U.S. Food and Drug Administration for commercial use.
The V6 is positioned as a versatile solution for clinicians, delivering comprehensive imaging capabilities in 2D, 3D, and color image quality. It aims to meet the imaging demands of medical professionals while being budget-friendly and enhancing workflow and productivity.
Advanced Imaging Technology: The V6, powered by Samsung’s Crystal Architecture™ imaging platform, offers enhanced image clarity and advanced automated tools.
miniER7 Endocavity Transducer: Designed for patient comfort, this transducer features a 180° field of view and a 2-12 MHz frequency range, reducing patient discomfort during procedures.
ViewAssist™: An artificial intelligence (AI) feature that automates the recognition of imaging planes and labels anatomy, streamlining documentation and enhancing exam workflow.
BiometryAssist™: A semi-automated feature based on Deep Learning that enables one-click fetal growth measurements, providing exam consistency and reducing keystrokes.
UterineAssist™: An AI technology tool for automatically measuring the size and shape of the uterus, aiding in the detection of uterine-related abnormalities.
Mobile Export: A secure image-sharing solution allowing instant sharing of fetal images with patients through a simple QR code.
SonoSync™: A real-time image-sharing solution facilitating communication between doctors and sonographers through voice and text chatting, as well as real-time marking functions.
The V6 has undergone rigorous evaluations for safety and effectiveness, conforming to FDA guidelines and medical device safety standards. It also integrates with Cycle Clarity’s AI-based software platform, making it suitable for the reproductive endocrinology and infertility setting.
Samsung Medison, a global leading medical device company, aims to bring transformative technologies to the healthcare industry. Boston Imaging, the U.S. headquarters for Samsung’s digital radiography and ultrasound systems, markets innovative imaging technologies to healthcare providers. Cycle Clarity, a software company, focuses on enhancing fertility treatment through cognitive computing in healthcare.
Generative AI Takes Center Stage in iPhone 16’s Exclusive Features
Apple is developing iOS 18 with exclusive AI features for the iPhone...